AR090307A1 - Polimeros cationicos a base de glucogeno - Google Patents

Polimeros cationicos a base de glucogeno

Info

Publication number
AR090307A1
AR090307A1 ARP130100787A ARP130100787A AR090307A1 AR 090307 A1 AR090307 A1 AR 090307A1 AR P130100787 A ARP130100787 A AR P130100787A AR P130100787 A ARP130100787 A AR P130100787A AR 090307 A1 AR090307 A1 AR 090307A1
Authority
AR
Argentina
Prior art keywords
glucogen
cationic polymers
based cationic
complexes
cationic
Prior art date
Application number
ARP130100787A
Other languages
English (en)
Inventor
Russo Vincenzo
Liberati Elisa
Cazzolla Nicola
Original Assignee
Acraf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Acraf filed Critical Acraf
Publication of AR090307A1 publication Critical patent/AR090307A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/18—Reserve carbohydrates, e.g. glycogen, inulin, laminarin; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A61K31/713—Double-stranded nucleic acids or oligonucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Materials Engineering (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Compositions Of Macromolecular Compounds (AREA)

Abstract

La presente se refiere a polímeros catiónicos a base de glucógeno, a complejos de dichos polímeros catiónicos con compuestos aniónicos, a composiciones farmacéuticas que comprenden dichos complejos y a la utilización de dichos complejos para administrar o transfectar dichos compuestos aniónicos a una diana farmacológica específica, tal como por ejemplo un órgano, un tejido o una célula.
ARP130100787A 2012-03-15 2013-03-12 Polimeros cationicos a base de glucogeno AR090307A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP12159710 2012-03-15

Publications (1)

Publication Number Publication Date
AR090307A1 true AR090307A1 (es) 2014-11-05

Family

ID=47739282

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP130100787A AR090307A1 (es) 2012-03-15 2013-03-12 Polimeros cationicos a base de glucogeno

Country Status (29)

Country Link
US (1) US9717801B2 (es)
EP (1) EP2825565B1 (es)
JP (1) JP6247234B2 (es)
KR (1) KR101997018B1 (es)
CN (2) CN107236052B (es)
AR (1) AR090307A1 (es)
AU (1) AU2013231561B2 (es)
BR (1) BR112014018617A8 (es)
CA (1) CA2859273C (es)
CY (1) CY1121829T1 (es)
DK (1) DK2825565T3 (es)
EA (1) EA032479B1 (es)
ES (1) ES2732216T3 (es)
GE (1) GEP201606581B (es)
HK (1) HK1203984A1 (es)
HR (1) HRP20191114T1 (es)
HU (1) HUE045049T2 (es)
IL (1) IL233823B (es)
LT (1) LT2825565T (es)
ME (1) ME03429B (es)
MX (1) MX351599B (es)
PL (1) PL2825565T3 (es)
PT (1) PT2825565T (es)
RS (1) RS58985B1 (es)
SG (2) SG10201607577QA (es)
SI (1) SI2825565T1 (es)
TR (1) TR201909387T4 (es)
UA (1) UA115135C2 (es)
WO (1) WO2013135471A1 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR095937A1 (es) 2013-04-05 2015-11-25 Acraf Potenciador de la solubilidad en agua a base de glucógeno
CA2910399C (en) 2013-04-26 2021-05-18 Mirexus Biotechnologies Inc. Phytoglycogen nanoparticles and methods of manufacture thereof
WO2016108264A1 (ja) * 2014-12-29 2016-07-07 株式会社ボナック 核酸分子を安定に含有する組成物
CN104558246B (zh) * 2015-01-20 2017-03-01 武汉理工大学 一种叶酸/生物素修饰的壳聚糖材料及其制备方法
DE102015205088C5 (de) * 2015-03-20 2024-09-26 Kuka Deutschland Gmbh Verfahren zum Ermitteln eines Kalibrierungsparameters eines Fahrzeuges sowie Fahrzeug hierzu
JP6872782B2 (ja) * 2016-03-08 2021-05-19 国立大学法人京都大学 カチオン性グルカンナノスフェア、複合体、核酸導入剤及びがん治療剤
WO2017177342A1 (en) * 2016-04-14 2017-10-19 Mirexus Biotechnologies Inc. Anti-infective compositions comprising phytoglycogen nanoparticles
BR112018072452A2 (pt) * 2016-05-04 2019-02-19 Mirexus Biotechnologies Inc. nanopartículas de glicogênio e fitoglicogênio como compostos imunossupressores, e composições e métodos para uso dos mesmos
CN105949344B (zh) * 2016-05-13 2019-05-17 中山大学 一种阳离子超支化多糖衍生物及其在增强血卟啉类光敏剂对肿瘤细胞光毒性方面的应用
WO2019027999A1 (en) * 2017-07-31 2019-02-07 Ohio State Innovation Foundation BIOMIMETIC NANOMATERIALS AND USES THEREOF
WO2019140304A1 (en) * 2018-01-11 2019-07-18 Virgina Tech Intellectual Properties Inc. Amphiphilic polysacchardides,polysaccharide-based hydrogels, and methods of manufacture

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8904370D0 (en) * 1989-02-25 1989-04-12 Cosmas Damian Ltd Liquid delivery compositions
IT1255488B (it) 1992-08-04 1995-11-06 Angelini Francesco Ist Ricerca Polisaccaridi del glicogeno
US7144713B1 (en) 1995-10-02 2006-12-05 Emd Biosciences, Inc. Method for precipitating nucleic acid with visible carrier
GB9600272D0 (en) 1996-01-06 1996-03-06 Univ Nottingham Polymers
US6106858A (en) * 1997-09-08 2000-08-22 Skyepharma, Inc. Modulation of drug loading in multivescular liposomes
WO2002100435A1 (en) 2001-06-11 2002-12-19 Centre Hospitalier Universitaire De Montreal Compositions and methods for enhancing nucleic acid transfer into cells
US20030147958A1 (en) 2002-01-29 2003-08-07 Cheol-Hee Ahn Biodegradable multi-block copolymers of poly(amino acid)s and poly(ethylene glycol) for the delivery of bioactive agents
WO2003078576A2 (en) 2002-03-12 2003-09-25 Nitto Denko Corporation Vector for transfection of eukaryotic cells
US20090117657A1 (en) 2004-03-31 2009-05-07 Medgel Corporation Preparation For Transferring Nucleic Acid Into Cell
WO2007038769A1 (en) 2005-09-28 2007-04-05 Hetzel Adrian H Electro-hydraulic timed angle controlled joint simulation torque calibration, certification and analysis device
UA97559C2 (uk) 2007-11-08 2012-02-27 Оцука Фармасьютікал Ко., Лтд. Комплекс нуклеїнової кислоти і композиція для доставки нуклеїнової кислоти
CN101235098A (zh) * 2008-01-09 2008-08-06 浙江大学 功能性植物多糖的修饰方法
WO2010072627A1 (en) * 2008-12-22 2010-07-01 Unilever Plc Laundry compositions
EP2366009B1 (en) * 2008-12-22 2012-10-24 Unilever PLC Laundry compositions
WO2010128601A1 (ja) 2009-05-08 2010-11-11 国立大学法人 鹿児島大学 グルクロン酸含有グルカン、その製造法および利用
EP2275085A1 (en) * 2009-07-07 2011-01-19 University of Rostock Biodegradable copolymer suitable for delivering nucleic acid materials into cells
CN102068698A (zh) * 2009-11-24 2011-05-25 深圳先进技术研究院 纳米疫苗及其制备方法

Also Published As

Publication number Publication date
MX2014010698A (es) 2015-03-10
JP6247234B2 (ja) 2017-12-13
LT2825565T (lt) 2019-07-10
AU2013231561A1 (en) 2014-07-10
GEP201606581B (en) 2016-11-25
SI2825565T1 (sl) 2019-08-30
SG10201607577QA (en) 2016-11-29
EP2825565A1 (en) 2015-01-21
IL233823A0 (en) 2014-09-30
KR101997018B1 (ko) 2019-07-05
US20140378532A1 (en) 2014-12-25
UA115135C2 (uk) 2017-09-25
WO2013135471A1 (en) 2013-09-19
PL2825565T3 (pl) 2019-10-31
IL233823B (en) 2018-05-31
HK1203984A1 (en) 2015-11-06
RS58985B1 (sr) 2019-08-30
HUE045049T2 (hu) 2019-12-30
DK2825565T3 (da) 2019-06-24
CA2859273A1 (en) 2013-09-19
CN104080812B (zh) 2017-06-27
EA201491613A1 (ru) 2014-12-30
ES2732216T3 (es) 2019-11-21
PT2825565T (pt) 2019-07-10
CN107236052A (zh) 2017-10-10
AU2013231561B2 (en) 2017-06-08
US9717801B2 (en) 2017-08-01
ME03429B (me) 2020-01-20
EA032479B1 (ru) 2019-06-28
MX351599B (es) 2017-10-20
CY1121829T1 (el) 2020-07-31
BR112014018617A2 (es) 2017-06-20
SG11201403816YA (en) 2014-08-28
EP2825565B1 (en) 2019-04-03
KR20150006414A (ko) 2015-01-16
CA2859273C (en) 2020-04-14
BR112014018617A8 (pt) 2017-07-11
JP2015510020A (ja) 2015-04-02
HRP20191114T1 (hr) 2019-09-20
CN104080812A (zh) 2014-10-01
CN107236052B (zh) 2019-09-24
TR201909387T4 (tr) 2019-07-22

Similar Documents

Publication Publication Date Title
AR090307A1 (es) Polimeros cationicos a base de glucogeno
BR112014032990A2 (pt) seringa
UY35812A (es) ?loci de maíz óptimos?.
UY35815A (es) ?locus óptimos del maíz?
BR112015011118A2 (pt) conjugado; composição farmacêutica; e uso de um ou mais dos conjugados
UY34566A (es) 1,4?dihidropirimidinas 4,4?disustituidas y su uso como medicamentos para el tratamiento de la hepatitis b
BR112016026291A2 (pt) Derivados do ácido borônico e usos terapêuticos dos mesmos
EA201690780A1 (ru) Пегилированные лекарственные средства-линкеры для улучшенной фармакокинетики конъюгатов лиганд-лекарственное средство
UY34918A (es) Nuevos ácidos 5-aminotetrahidroquinolin-2-carboxílicos y su uso
DK2912074T4 (da) Dermal injicerbar steril sammensætning
GT201200334A (es) Morfolinopirimidinas y su uso en terapia
MX2016008448A (es) Conjugados de var2csa-farmaco.
BR112013007362A2 (pt) composição farmacêutica
MX352245B (es) Formulacion farmaceutica que comprende una droga biofarmaceutica.
UY34627A (es) Triterpenoides de c-3 cicloalquenilo con actividad inhibidora de la maduración del vih
AR125920A2 (es) Composiciones que comprenden vortioxetina y donepezil
BR112014025041B8 (pt) Composição farmacêutica
TR201821285T4 (tr) CCR3 antagonisti içeren farmasötik formülasyonlar.
DOP2015000060A (es) Profármacos de aminoquinazolina inhibidora de cinasa
UY34610A (es) Pirroldicarboxamidas condensadas y su uso como agentes farmacéuticos.
BR112016017010A2 (pt) Anticorpo monoclonal de fator antitecido
BR112017006552A2 (pt) composições e métodos para inibir a atividade biológica de biomoléculas solúveis
CU20140132A7 (es) Métodos de quelatos de oligonucleótidos
BR112016011899A2 (pt) Processo para preparação de 5-fluoro-1h-pirazóis
BR112014028443A2 (pt) composição estéril.

Legal Events

Date Code Title Description
FG Grant, registration